Skip to main content

Table 2 Derivation of analysis population

From: Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases

 

Database

 
 

MedStat

PharMetrics

i3-Ingenix

Total

All patients in the database

41,105,604

>60,000,000

22,689,623

>123,795,227

   And filled prescription for latanoprost or travoprost-Z 10/2006 - Q2/2008

152,961

69,298

42,424

264,683

   And continuous enrollment 6 months prior through 12 months after index date

84,871

35,447

23,091

143,409

   And any open-angle glaucoma or ocular hypertension* diagnosis within 90 days prior to index date

31,760

14,713

9107

55,580

   And no ocular surface disease* during 180 days prior to index date

28,711

12,833

7597

49,141

   And no prescription for the index agent in 180 days prior to index date

15,154

4151

4298

23,603

  1. *Defined in Table 1.
  2. Index date = date of initial prescription for latanoprost or travoprost-Z; Q2 = second quarter.